Q4 2023 Holdings
Filed 2024-02-14 | 34 holdings | $586.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $70.6M | 3,703,433 | 12.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $41.7M | 500,000 | 7.1% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $39.3M | 2,620,545 | 6.7% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $33.0M | 1,823,184 | 5.6% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $31.0M | 648,000 | 5.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $27.6M | 600,000 | 4.7% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $27.3M | 1,099,753 | 4.7% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $24.3M | 875,044 | 4.1% |
| Aerovate Therapeutics Inc | COM | 008064107 | $23.5M | 1,037,690 | 4.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $22.6M | 360,000 | 3.9% |
| Evolus Inc(EOLS) | COM | 30052C107 | $21.1M | 2,000,000 | 3.6% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $20.9M | 976,981 | 3.6% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $20.0M | 293,000 | 3.4% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $19.3M | 994,229 | 3.3% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $18.2M | 1,280,500 | 3.1% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $17.6M | 672,885 | 3.0% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $16.6M | 1,550,000 | 2.8% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $15.4M | 3,295,000 | 2.6% |
| Optinose Inc | COM | 68404V100 | $11.4M | 8,839,939 | 1.9% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $11.2M | 400,000 | 1.9% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $9.6M | 234,082 | 1.6% |
| Karuna Therapeutics Inc | COM | 48576A100 | $9.6M | 30,250 | 1.6% |
| Vistagen Therapeutics Inc(VTGN) | COM | 92840H400 | $9.6M | 1,858,735 | 1.6% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $8.5M | 1,309,975 | 1.4% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $7.9M | 110,607 | 1.4% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $7.7M | 80,000 | 1.3% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $7.0M | 225,912 | 1.2% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $4.7M | 1,093,273 | 0.8% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $3.1M | 700,000 | 0.5% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $2.7M | 125,000 | 0.5% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $2.7M | 48,264 | 0.5% |
| Merus N V | COM | N5749R100 | $550.0K | 20,000 | 0.1% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $395.0K | 4,963 | 0.1% |
| Mural Oncology PUB LTD Co | ORD SHS | G63365103 | $68.1K | 11,509 | 0.0% |